EIT-URBAN-MOBILITY
16.11.2021 09:02:12 CET | Business Wire | Press release
Tomorrow.Mobility World Congress (TMWC) is a new global event, co-organised by Fira de Barcelona and EIT Urban Mobility, focused on promoting the design and adoption of new sustainable urban mobility models. TMWC is being launched to create a global benchmark in the field of mobility and to go beyond a one-off event, as it will include an online knowledge platform that will be active throughout the year and an innovation hub set to bring the main players in the industry together.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211116005046/en/
EIT Urban Mobility is the largest European initiative for the transformation of urban mobility, created by the European Institute of Innovation and Technology (EIT), a body of the European Union. This European initiative benefits of the strategic partnership with Fira de Barcelona by increasing the impact of its European partnership and jointly reaching to a wider audience globally in the mobility scene. Tomorrow.Mobility represents EIT Urban Mobility’s flagship event 2021, showcasing its most promising innovation projects, results, demonstrations, and supported start-ups.
TMWC will bring insights from the global mobility ecosystem gathered under one roof. Being aware of the strong ties that mobility has with other sectors, the event is co-located with Smart City Expo World Congress (SCEWC). More than 350 speakers will be joining alongside hundreds of exhibitors and thousands of attendees. Twelve inspiring congress sessions featuring high-level speakers from both the public and private sector will take place under the umbrella of Tomorrow.Mobility. Speakers include Maria Tsavachidis, CEO of EIT Urban Mobility & President of the Board of Tomorrow.Mobility; Matthew Baldwin, Deputy Director-General for DG MOVE, European Commission; Mark Major, Senior Advisor to the Partnership on Sustainable, Low Carbon Transport (SLoCaT); Carlos Moreno, Scientific director of the Chair Entrepreneurship Territory Innovation, University Panthéon Sorbonne – IAE Paris; and Anna Lisa Boni, Secretary General at Eurocities.
Dr. Maria Tsavachidis, CEO of EIT Urban Mobility & President of the Advisory Board of TMWC stated that “our collaboration with Fira de Barcelona will help expand the network of innovation for urban mobility in Europe and beyond. Our goal is to foster innovation and transformation towards sustainable mobility, to decarbonise mobility, improve people’s quality of life, and make Europe’s economy more competitive. Bringing together the world´s leaders and frontrunners in sustainable mobility under the umbrella of Tomorrow.Mobility is an important steppingstone towards this goal. It will inspire and create new opportunities for our partners, cities, startups, and their innovations ”.
Numerous start-ups supported by EIT Urban Mobility will be showcasing their high-tech solutions at their booths and demo areas, such as: Bia Power (Autonomous Vehicles/Spain), BlockCity (Mobility Services/Hungary), Dashfactory Gmbh (Sensors & Training Data/Germany), Delivers.ai (Last Mile Delivery/Turkey), Vianova (Sensors Data/France), and SmartMonkey (Green Logistics/Spain).
Several EIT Urban Mobility supported innovation projects will be featured at the Central Agora during two different sessions. One session focusing on managing shared public space, and another on how to put Mobility as a Service (MaaS) solutions into practice. Among the EIT Urban Mobility supported projects presented are, FURNISH , which promotes the redesign of public spaces to prevent the spread of COVID-19. Another notable project is HALLO, which creates shared urban consolidation and distribution centres through a series of pilots in Barcelona and Stockholm.
Tomorrow.Mobility, held with the Smart City Expo World Congress (SCEWC), a leading tradeshow & congress on smart cities, has the initial support of over a hundred global companies and trusted institutions amongst which feature the World Bank, the World Economic Forum, the United Nations, Microsoft, Mastercard, ADP (Airports of Paris), the International Association of Ports and Harbours, the Port of Barcelona, Moventia, the RACC and Social Car. The event seeks to tackle the future challenges facing mobility, an industry that will be one of the main drivers of future growth, with a market volume of 60,000 million euros in 2027.
The new event, which will include a congress and exhibition area, will hold a first pilot edition in November and again in 2022. It will address current mobility challenge areas such as micromobility (electric scooters, bicycles), active mobility and the public realm, public transport, mobility providers (car sharing, air taxis), the car industry (electric, connected, and autonomous cars), last mile logistics (e-commerce deliveries, delivery drones), smart infrastructures (fleet management, geolocation, and payment systems), the energy transition towards carbon neutrality and digitisation.
The objective of Tomorrow.Mobility is to go beyond being just an event. The launch of the new show will be accompanied by the creation of a digital content platform with a global reach operating 365 days a year, turning it into the go-to global stage for urban, sustainable, and smart mobility. This platform will allow access to both live events and à la carte contents divided into themes with the aim of facilitating knowledge transfer, training & network.
Practical information
- Dates: 16, 17 & 18 November 2021
- Opening hours: Tue & Wed: 9.00-19.00 CET | Thu: 9.00-17.00 CET
-
Location:
Fira de Barcelona Gran Via – Halls 1 & 2 -
Av. Joan Carles I, 64 - 08908 L’Hospitalet de Llobregat, Barcelona, Spain - EIT Urban Mobility Booth @ Tomorrow.Mobility: Street D, Stand 174
- Event website: www.tomorrowmobility.com
BACKGROUND
About EIT Urban Mobility
EIT Urban Mobility, an initiative of the European Institute of Innovation and Technology (EIT)
, a body of the European Union, aims to accelerate solutions and the transition towards a user-centric, integrated and truly multimodal transport system. As the leading European innovation community for urban mobility, EIT Urban Mobility works to avoid fragmentation by facilitating collaboration between cities, industry, academia, research and innovation to solve the most pressing mobility challenges of cities. Using cities as living labs, its industry, research and university partners will demonstrate how new technologies can work to solve real problems in real cities by transporting people, goods and waste in smarter ways.
For more information visit www.eiturbanmobility.eu .
Follow EIT Urban Mobility on: Linkedin Twitter Facebook Youtube Instagram
View source version on businesswire.com: https://www.businesswire.com/news/home/20211116005046/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
DEWA Organises Second Agentic AI Retreat at Al Shera’a, World’s Tallest, Largest and Smartest Net‑Positive Government Building12.6.2026 17:08:00 CEST | Press release
HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA),has emphasised that DEWA deploys the latest Agentic AI technologies, in line with the vision to enhance its leading role and reinforce Dubai’s position as the city of the future. He made these remarks during the Agentic AI Executive Retreat DEWA organised at Al Shera’a, its new headquarters, which is the world’s tallest, largest and smartest net-positive government building. The event was attended by the executive leadership team and key stakeholders in digital transformation and artificial intelligence (AI), as well as representatives from SAP and McKinsey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612633834/en/ DEWA organises second Agentic AI Retreat at Al Shera’a, world’s tallest, largest and smartest net positive government building (Photo: AETOSWire) In his speech, Al Tayer said that DEWA is guided by directives from the wise l
BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 202612.6.2026 12:00:00 CEST | Press release
Tacabrutideg (BGB-16673, BTK degrader) showed durable responses in heavily pretreated R/R CLL and BTK inhibitor–naïve patients, signaling potential for earlier lines of treatmentBRUKINSA plus sonrotoclax (ZS) delivered deep, durable responses and high uMRD rates across TN CLL and R/R MCL and CLL, reinforcing its potential as an all-oral, fixed-duration treatment BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from its foundational hematology franchise at the 2026 European Hematology Association (EHA) Congress in Stockholm. Updated results from tacabrutideg (BGB-16673), a potential best-in-class Bruton’s tyrosine kinase (BTK) degrader, demonstrated durable responses in pretreated relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), with early activity also seen in BTK inhibitor–naïve patients. These data are complemented by results from the all-oral combination of BRUKINSA® (zanubru
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
